Linked Data API

Show Search Form

Search Results

753958
star this property human indexable true more like this
star this property published true more like this
star this property registered interest false more like this
star this property answer date less than 2017-08-02more like thismore than 2017-08-02
star this property date less than 2017-07-19more like thismore than 2017-07-19
star this property date tabled less than 2017-07-19more like thismore than 2017-07-19
star this property answering body
Department of Health more like this
star this property question status Tabled more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property ddp created
less than 2017-07-19T22:26:10.596Zmore like thismore than 2017-07-19T22:26:10.596Z
less than 2017-07-19T22:26:10.597Zmore like thismore than 2017-07-19T22:26:10.597Z
star this property ddp modified
less than 2017-07-19T22:26:10.596Zmore like thismore than 2017-07-19T22:26:10.596Z
less than 2017-07-31T14:11:05.416Zmore like thismore than 2017-07-31T14:11:05.416Z
unstar this property hansard heading Radioisotopes: Imports more like this
star this property house id 2 more like this
star this property identifier HL1104 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property parliament number 57 more like this
star this property question first answered
less than 2017-07-31T13:38:56.527Zmore like thismore than 2017-07-31T13:38:56.527Z
star this property question text Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit. more like this
star this property session
2017/19 more like this
star this property session number 1 more like this
star this property tabling member printed
Lord Mendelsohn more like this
star this property title House of Lords Tabled Parliamentary Question 2017/19 HL1104 remove filter
star this property type
WrittenParliamentaryQuestion
star this property uin HL1104 more like this
star this property version 1 more like this
star this property written parliamentary question type Ordinary more like this
unstar this property answer answer
star this property creator
4286
star this property label Biography information for Lord Mendelsohn more like this
star this property publisher
25277
star this property pref label House of Lords more like this
star this property tabling member
4286
unstar this property label Biography information for Lord Mendelsohn more like this